Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer

Journal of Thoracic Oncology

Volumn 10, Issue 8, 2015, Pages 1201-1206

  Ezer, Nicole ^a,b   Veluswamy, Rajwanth R ^b   Mhango, Grace ^b   Rosenzweig, Kenneth E ^c   Powell, Charles A ^d   Wisnivesky, Juan P ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b Division of General Internal Medicine   (United States)

^c Department of Radiation Oncology ^*  (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Non small cell lung cancer; Radiosurgery.; Radiotherapy; Segmentectomy; Wedge resection

Indexed keywords

AGED; ARTICLE; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; EARLY CANCER; ESOPHAGITIS; FEMALE; HEMOPTYSIS; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION PNEUMONIA; RESPIRATORY TRACT DISEASE; STEREOTACTIC BODY RADIATION THERAPY; THROMBOEMBOLISM; WEDGE RESECTION; ADVERSE EFFECTS; AGE; CANCER REGISTRY; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; PROPENSITY SCORE; RADIOSURGERY; SURVIVAL RATE; TUMOR VOLUME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; PROPENSITY SCORE; RADIOSURGERY; SEER PROGRAM; SURVIVAL RATE; TUMOR BURDEN;

EID: 84942857253     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000600     Document Type: Article

References (36)

1. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Potters L, Kavanagh B, Galvin JM, et al.; American Society for Therapeutic Radiology and Oncology; American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010;76:326-332.
3. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-1076.
4. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-682.
5. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290-3296.
6. Wang SM, Kung PT, Wang YH, Huang KH, Tsai WC. Effects of multidisciplinary team care on utilization of emergency care for patients with lung cancer. Am J Manag Care 2014;20:e353-e364.
7. Cheung WY, Butler JR, Kliewer EV, et al. Analysis of wait times and costs during the peri-diagnostic period for non-small cell lung cancer. Lung Cancer 2011;72:125-131.
8. National-Cancer-Institute. Surveillance epidemiology and end results database. Available at http://seer.cancer.gov/. Accessed February 1, 2014.
9. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
10. Wisnivesky JP, Smith CB, Packer S, et al. Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study. BMJ 2011;343:d4013.
11. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009;136:260-271.
12. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002;40(8 Suppl):IV-43.
13. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002;40(8 Suppl):IV-49.
14. Iezzoni LI, Daley J, Heeren T, et al. Identifying complications of care using administrative data. Med Care 1994;32:700-715.
15. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002;20:4636-4642.
16. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-1358.
17. Timmerman RD. Surgery versus stereotactic body radiation therapy for earlystage lung cancer: whos down for the count? J Clin Oncol 2010;28:907-909.
18. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2001:CD002935.
19. Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005;128:1461-1467.
20. Nyman J, Hallqvist A, Lund JA, Brustugun OT, Bergstrm P, Friesland S, Lewensohn R, Drugge N, Rylander H, Lax I. SPACE-A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. ESTRO 2014. Abstract OC-0565.
21. Fernando HC, Timmerman R. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2012;144:S35-S38.
22. Forrest LF, Adams J, White M, Rubin G. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study. Br J Cancer 2014;111:1843-1851.
23. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010;28:928-935.
24. Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-Assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 2013;24:1543-1548.
25. Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013;119:2683-2691.
26. Haasbeek CJ, Palma D, Visser O, Lagerwaard FJ, Slotman B, Senan S. Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol 2012;23:2743-2747.
27. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010;28:5153-5159.
28. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012;84:1060-1070.
29. Shirvani SM, Jiang J, Chang JY, et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg 2014;149:1244-1253.
30. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging nonsmall cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e211S-e250S.
31. Kent M, Landreneau R, Mandrekar S, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg 2013;96:1747-1754; discussion 1754.
32. Smith CB, Swanson SJ, Mhango G, Wisnivesky JP. Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer. J Thorac Oncol 2013;8:73-78.
33. Zhao X, Qian L, Luo Q, Huang J. Segmentectomy as a safe and equally effective surgical option under complete video-Assisted thoracic surgery for patients of stage I non-small cell lung cancer. J Cardiothorac Surg 2013;8:116.
34. Nakamura H, Taniguchi Y, Miwa K, et al. Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer. Thorac Cardiovasc Surg 2011;59:137-141.
35. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-775.
36. Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD. A survey of stereotactic body radiotherapy use in the United States. Cancer 2011;117:4566-4572.